
|Videos|July 24, 2018
MDS/MPN Overlap Syndromes and Myelofibrosis
Author(s)Aplastic Anemia, MDS International Foundation
Dr. Eric Padrone, a hematologist from H. Lee Moffit Cancer Center, discusses current thinking on MDS/MPN overlap disorders and myelofibrosis.
Advertisement
Dr. Eric Padrone, a hematologist from H. Lee Moffit Cancer Center, discusses current thinking on MDS/MPN overlap disorders and myelofibrosis.
The following questions are answered:
What are MDS/MPN overlap disorders? (CMML, etc.)
What is myelofibrosis? What are the current treatments for MDS/MPN overlap and myelofibrosis?
What treatments or treatment approaches are coming in the future? What might these mean for patients?
This video was recorded at the Aplastic Anemia and MDS International Foundation's Scientific Symposium in March, 2018.
Advertisement
Advertisement
Advertisement
Trending on CURE
1
5 Years of Prostate Cancer Advances: A Timeline of FDA Approvals and What They Mean for Patients
2
FDA Withdraws Krazati/Erbitux Approval in KRAS G12C-Mutated Colorectal Cancer
3
FDA Grants Accelerated Approval to Hyrnuo for Certain Patients With HER2-Mutated NSCLC
4
The Oncology Nurse Who Got Me Through 2 Years of Cancer Treatment
5




